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Abstract 
This thesis focuses on the modelling and prediction of factors affecting attendance to 
screening invitations of the NHS Breast Screening Programme. The analysis is based 
on data collected by the Warwickshire, Solihull and Coventry Breast Screening Unit 
from 1989 up to 2001 with respect to invitation to screening for the prevention of 
breast cancer in non-symptomatic women. 
Using a novel approach to the analysis of the data, from the perspective of the 
screening episode of each woman, rather than the usual analysis from the perspective 
of the screening round of the units, a statistical analysis is carried out on the whole 
registered population for the first time. Amendments to the current formulae for 
coverage calculations, the introduction of a new parameter (invitation rate) and the 
proposal for a reduction of the invitation period (period of time between two 
consecutive invitations) follows from the analysis. 
A preliminary analysis of predictive methodologies, including traditional statistical 
methods and artificial intelligent methods, gives the foundation to the formulation of 
two new algorithms; the first, for the prediction of attendance of women to screening 
invitations, and the second for the prediction of occurrence of screening variation 
( change of appointment dates) of women to invitations. Both algorithms are based on 
neural network generated models able to learn from the previous screening behaviour 
history of the woman, a technique not previously explored for the prediction of 
attendance. 
The accuracy of the new proposed algorithm for the prediction of attendance to 
invitation is tested on a blind study using data not previously seen by the predictive 
system, and for which results were unknown at the time when the predictions were 
made. 
From the obtained results, it is concluded to recommend the implementation by the 
NHS Breast Screening Unit of the two algorithms proposed for the prediction of the 
women' s attendance and screening variation to their invitation for screening. With 
these predictions, women likely not to attend, or change appointment date, can be 
identified and appropriately targeted with the aim of increasing their attendance in the 
short term, and in the long term, reducing breast cancer mortality. 
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Glossary 
Given the number of variables involved in the present work, a separate explanation of 
their definitions would be of assistance. There are two groups of variables, those 
relating to each woman and those variables defined for all women. 
The variables repeated in each screening episode are defined in the same way for each 
one of them. A number added at the end of the name will specify to which episode the 
variable refers, e.g. FOAI, FOA2, etc. 
The present work involves also two different ways of defining the screening year, one 
which ends on the 31 st of March (current mode of measurement), and another, which 
ends on the 31 st December. The annual variables are defined in the same way in both 
cases. A suffix in the name (D for December and M for March) will show which mode of 
measurement the variable refers to (Eg. NuminvD or NumscrM). 
Ageband 
Categorical variable assuming the following values; 
1 < 50 years old at invitation 
2 50 -54 years old at invitation 
3 55-59 years old at invitation 
4 60-64 years old at invitation 
5 > 64 years old at invitation. 
(0 if no invitations have been made) 
V 
AgeFOA 
Age at First Offered Appointment (FOA). Number of years between DOB and 
FOA (measured as an integer). 
Att (Attendance) 





invited but did not attend 
invited and screened 
if no invitation) 
Cancer 
Binary variable 
0 no breast cancer detected in the screening episode 
1 breast cancer detected 
Coverage 
DOB 
Proportion of women screened to eligible population in a given year, normalised 
to values between O and 1. 
Date of birth. This is a date variable. (Note that in SPSS, all date formats are 
internally stored as the number of seconds from October 14, 1582.) 
VI 
DOS 
Date of first screening for the episode (SPSS-recorded date variable). 
Early recall 





Denotes the period of time elapsed between the first invitation of a particular 
woman up to the final outcome of her screening for that invitation. 
Binary variable 
0 no false positive result in the previous episode 
1 false positive result in the previous episode 
Date of first offered appointment. (SPSS-recorded date variable) 
Histcan 
Binary variable 
0 no previous history of breast cancer detection 




0 no previous history of false positive results 
1 previous history of false positive results 
Interval cancer 
Cancers detected between screening episodes. 
Intslip (Screening variation by intervals) 
This is an integer variable that takes values depending on the screening 
variation value (women changes of appointments) as follows: 
Table I. SCREENING VARIATION BY INTERVALS (INTSLIP) DEFINITIONS 
With 
respect to 
Value If appointment date is Days the 
invitaUon 
date 
-8 more than three vears >1000 before 
-7 more than one vear but up to three years [357-1000] before 
-6 more than six months but up to one year [181 - 356] before 
-5 more than three months but up to six months 91 -180 before 
-4 more than one month but up to three months 31 -90 before 
-3 more than two weeks but up to one month 15-30 before 
-2 more than one week but uo to two weeks 8-14 before 
-1 one or more davs but uo to one week [1 - 71 before 
0 no screening variation 0 on the day 
1 one or more days but up to one week [1 - 7] after 
2 more than one week but up to two weeks 8-14 after 
3 more than two weeks but up to one month 15-30 after 
4 more than one month but up to three months 31 -90 after 
5 more than three months but uo to six months 91 -180 after 
6 more than six months but up to one year [181 -356] after 
7 more than one year but up to three years [357-1000] after 
8 more than three years >1000 after 
Invitation period 






Proportion of women invited to eligible population in a given year, normalised to 
values between O and 1. 
National Statistics (return from the Screening Office). 
National Statistics (return from the Health Authority). 
Lengbs 
(Round Length by British Standards) 
[FO A ( episode x+ 1) - DOS ( episode x)] 
Also known as slippage, this is a discrete variable which measures the difference 
in years between the date of last screening and the date of next first offered 
appointment. It is calculated as the difference in days divided by the number of 
days in a year, and rounded to the nearest integer. 
Non-eligible women 
Women excluded from the system because of either bilateral mastectomy or 
terminal illness. 
Numinv 
(Number of women invited) 
Number of women invited in a given time period. 
lX 
Numscr 
(Number of women screened) 
Number of women screened in a given time period. 
Numtest 
Number of tests women undergo in a single screening episode before final result for 
the episode. This variable is generated from the SEC. 
Population 
Number of eligible women in the population (aged between 50 - 64 years old) in 
a particular year. 
Postanum 
Integer equivalent to the three first characters of the Postal Code (for 
convenience). Thus, it is a categorical non-ordered variable. The correspondence 
1s: 
X 
1 B10 60 CF7 119 NN1 
2 B11 61 CH2 120 NN4 
3 B13 62 C04 121 NN5 
4 B14 63 CV1 122 NN6 
5 B15 64 CV2 123 NN7 
6 B17 65 CV3 124 NR1 
7 B23 66 CV4 125 NR2 
8 B24 67 CV5 126 NR3 
9 B25 68 CVS 127 OX1 
10 B26 69 CV7 128 OX2 
11 B27 70 CVS 129 OX7 
12 B28 71 CV9 130 PL2 
13 B32 72 DE1 131 PO1 
14 B33 73 DE2 132 PO3 
15 B34 74 DES 133 P04 
16 B36 75 DH3 134 RG4 
17 B37 76 DY1 135 S40 
18 B38 77 DYS 136 S45 
19 B40 78 DYS 137 SL6 
20 B45 79 EH6 138 SN1 
21 B46 80 EX1 139 SO3 
22 B47 81 EX2 140 S04 
23 B48 82 EX3 141 SY4 
24 B49 83 FK9 142 SY5 
25 B50 84 FY1 143 SYS 
26 867 85 FY8 144 TAB 
27 B72 86 GL1 145 TA9 
28 B73 87 GL2 146 TF1 
29 B74 88 GL5 147 TF2 
30 B75 89 GL6 148 TN5 
31 B76 90 HP3 149 TQ2 
32 B77 91 HR2 150 TQ9 
33 B78 92 HR3 151 TR1 
34 B79 93 HRS 152 TR2 
35 B8 94 HR7 153 TS7 
36 B80 95 HRS 154 UB7 
37 B9 96 HR9 155 W11 
38 B90 97 IG1 156 W3 
39 B91 98 IP2 157 WA1 
40 B92 99 KA1 158 WA4 
41 B93 100 KY7 159 WR1 
42 B94 101 LD2 160 WR2 
43 B95 102 LE1 161 WR3 
44 B96 103 LE2 162 WR4 
45 B97 104 LES 163 WR5 
46 B98 105 LE9 164 WR6 
47 BA1 106 LL1 165 WR7 
48 BA2 107 LL2 166 WR9 
49 BH1 108 LL4 167 WS1 
50 BH2 109 LL6 168 WS4 
51 BH4 110 LN1 169 WS7 
52 BN1 111 LN5 170 WV1 
53 8S1 112 LS1 171 YO1 
54 8S2 113 MK1 
55 BT8 114 MK4 
56 CA1 ~ 15 NE6 
57 CB1 116 NG1 
58 CB2 117 NG2 
59 CB3 118 NG3 
Roundle (Round length) 
[FOA (episode x+1) - FOA (episode x)] 
This variable measures the difference in years between the date of first offered 
appointment of one screening episode and the following one. It is calculated as 
Xl 
the difference in days divided by the number of days in a year and rounded to the 
nearest integer. 
Screening End Code (SEC) 
Categorical variable. It is a compilation of the outcomes of all the tests undergone 
by a woman in the screening episode. Table I gives the nomenclature used for the 
coding of the screening end code. 
Table II. SCREENING END CODE (SEC) DEFINITIONS 
Classification 
Normal outcome(-) 
Abnormal outcome (abn) 
Cancer Suspected 
Positive outcome (+) 
Screening Assessment Cytology Core biopsy 
(S) (A) (C) (W) 
S- A- C- W-
Sabn Aabn Cabn Wabn 








Difference in days between date of first offered appointment (FOA) and date of 
screening (DOS) for a given episode. It may assume negative and positive values: 
negative for days preceding FOA, and positive for days following FOA. Zero 
values imply no screening variation. However, no values will be assumed if 
neither invitation nor screening for the episode has occurred. 
A unique identification number for each individual. This is a numerical 
qualitative ordered variable, and gives information about how early or late a 
woman enters the system. The later the entry the higher the number. 
Xll 
Townsend Deprivation Score 
Measurement of socio-economic deprivation. It measures the level of deprivation 
based on housing, income, car ownership and educational level amongst other socio-
economic factors. The higher it is, the more deprived the area. 
Townsref 
Integer variable groupmg by interval the different values of the Townsend 
deprivation scores. It takes values: 
Type 
-3 -10 s Townsend s -8 (richest areas) 
-2 -7 S Townsend S-5 
-1 -4 :S: Townsend S -2 
0 -Is Townsend s I (average areas) 
1 2 S Townsend S 4 
2 5 S Townsend S 7 
3 8 s: Townsend s IO (poorest areas) 
Type of invitation for a given screening episode. This is a qualitative variable 





Qualitative variable, which may assume the values: 
Uptake 




No invitation for the episode) 
Percentage of women who, having been sent an invitation for screening in a 
given year, attend a screening unit and undergo mammography in response to 
that invitation. No allowances are made for returned letters or refusals. 





Breast cancer is the most common cancer in women worldwide, accounting for 
approximately 30% of all female malignancies. Quinn et al. [1] reported in the late 
1980's that mortality in England and Wales was not only higher than in most western 
European countries, but was amongst the highest in the world. Incidence, on the other 
hand, was similar to that in eastern European countries. In other words, survival was 
worse than in the rest of Europe. Although the reasons for such poorer survival rates 
remain unclear, there are suggestions that late diagnosis and poor adherence to 
treatment protocols may be contributing factors. 
Over the period 1993-95, the United Kingdom was identified, through the Global 
Breast Cancer Death Rates Statistics [2], to have the third highest breast cancer death 
rate in the world despite having a population-based breast cancer screening 
programme since 1987. This UK standing is alarming, though it hides the fact that, 
since 1989, the crude death rate due to breast cancer has decreased from 53.4 to 44.6 
per 100,000 in 1997, as documented in the WHO Databank [3]. 
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In 1997 there were 33,100 new registrations of breast cancer in women in England 
and Wales: almost 30% of all cancers in women [l]. The lifetime risk of being 
diagnosed with breast cancer is almost 11 % (1 in 9). Mortality has, however, declined 
since the late 1980' s. It began to fall soon after screening started (in all age groups), 
and by 1999, overall mortality was approximately 20% lower than the level attained 
in the 1980's. About one third of this decline is attributed directly to screening, and 
two thirds to improved treatment by tamoxifen and chemotherapy and to indirect 
effects of screening such as raised awareness leading to earlier presentation and 
diagnosis outside the screening programme. Also, since the early years of screening, 
there have been substantial improvements in sensitivity measurements as a result of 
the increased use of two-view mammography, the use of higher film densities, and 
increasing experience of radiologists. 
The NHS Breast Screening Programme was introduced in response to the 
recommendations of a working group chaired by Professor Sir Patrick Forrest [4] 
based on randomised controlled trials in America and Sweden. Its principal objective 
is to reduce mortality from breast cancer in the screened population. In order to 
achieve this objective, it targets to screen women aged between 50 and 64 every three 
years with the aim of detecting cancers at an earlier stage, when treatment is more 
effective. This should lead to a target reduction in mortality of 25% [5]. 
Continuous monitoring of the performance of the NHS Breast Screening Programme 
is essential. In the absence of a control population, a variety of proxy measures have 
been developed to evaluate the programme. The two principal factors identified as 
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affecting mortality reduction are improvements in cancer detection and population 
compliance. 
Amongst the proxy measures developed to evaluate the programme, are rates of 
screening detection of cancers, interval cancers, cancers in non-attenders [6], cancers 
in non-invited women, slippage [7] and attendance. These measures show the 
efficiency of the programme; therefore it is necessary to study them rigorously in 
order to (a) assist in reducing mortality and/or morbidity, and (b) perform quality 
assurance evaluations of the programme. 
Uptake and coverage have routinely been used to monitor the performance of 
screening units (8-10]. However, their underlying methods of calculation have varied 
over the years. It is therefore desirable to identify a unified model of measurement in 
order to carry out comparative studies and assist in forecasting their trends. 
Other factors playing an important role in the quality assurance of the programme are 
methods of data collection and storage. 
Numerous studies have been carried out in the UK and worldwide addressing some of 
the above issues. Notable examples are the follow-up of the Edinburgh trial in the UK 
(11,12], the systematic review of the UK Breast Screening Programme [13-17], critical 
assessments of efficacy (18-20], methods of screening (21,22], screening age [23] and 
various definitions (such as that for interval cancers (24]). Nevertheless, there are still 
questions to be answered and topics open to research. Topics such as the influence of 
attendance at previous episodes on the prediction of future attendance, the effect of 
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screening variation on uptake, and the improvement of the coverage formulation, are of 
current interest. These issues are addressed in this study. 
Since statistical methods of analysis have been successful in measuring the validity and 
performance of screening programmes (trials and population-based), as well as in 
modelling parameters involved in the achievements of particular units or regions [25-
31 ], these form the basis of an initial study. The subsequent predictive analysis is 
approached using artificial neural networks [32-39], rule induction algorithms [39], and 
decision trees [34,40,41]. These results are then compared with those of the traditional 
statistical logistic regression method [42-47], and represent an extension of existing 
work, within BIOCORE, related to clinical applications of intelligent computing in 
oncology [ 48-52]. 
1.2 Statement of the problem 
As stated in the introduction, most research carried out worldwide in this area is based 
on control-based studies. The UK Breast Cancer Screening Programme is a population-
based programme, and as a consequence, there is no control group to help in its 
assessment. This highlights the importance of proxy measurements in monitoring the 
effectiveness of the programme. Two of the most important measurements are uptake 
(measuring the performance of the invitation process) and coverage (measuring the 
efficiency of the programme in covering the whole population). However, both of these 
are aggregates of the number of women invited and the number of women screened, 
which are themselves aggregates of patient level variables. They are, therefore, overall 
meas~ements of the attendance of women at their invitation to screening. 
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The ways in which uptake and coverage have been measured have changed over time 
during the running the programme, but no assessment of the current formulae used has 
been performed, neither has there been any attempt to study their behaviour using a 
unified measurement. 
The literature shows many studies based on the influence of socio-economic factors on 
attendance and cancer death outcomes worldwide, but very little has been achieved on 
the influence of the intrinsic factors of the screening process affecting attendance from 
one episode to the next. 
Furthermore, very little research bas been performed to analyse the influence that 
changing screening appointments has on the overall measurements of uptake and 
coverage over a given time period. 
It is clear that early detection of malignancies is the most important factor in the battle to 
reduce breast cancer death, and the screening programme objective is to achieve this 
through mammography. However, very little can be achieved if women do not attend 
their appointments. Prediction of attendance in order to take decisive steps for improving 
the performance of the programme is a crucial matter. A statistical approach for 
forecasting attendance [53] was not successful, since it was based on aggregate data 
reported on the KC63 forms, and not from individual data. It is important to know not 
only the percentage of women who are likely to attend or not, but also to provide a tool 
that, given a particular woman and her screening history, will predict her future 
attendance and screening variation. With this information available, effective 
measurements could then be taken in order to increase the attendance of women at 
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screening. Furthermore, once the prediction for each woman is known, the uptake and 
coverage for a particular episode can also be predicted using their formulation in the 
predictive results rather than in the real data. 
Classical predictive statistical methods, such as Logistic Regression have proved to be 
very efficient tools for medical predictions in other fields. Nevertheless, the complex 
relationship structure of categorical variables involved in forecasting attendance and 
screening variation points to the need for using more powerful tools, like Artificial 
Neural Networks (ANNs), rule induction and add-hoc heuristic techniques which have 
been shown in the literature to be useful in the prediction of other cancer-related 
features. 
1.3 Aims 
The results presented in this thesis use data from the first ten years (3 ½ rounds) of 
screening at The Warwickshire, Solihull and Coventry Breast Screening Unit (a total of 
281,415 potential screenings for 147,432 women). 
The project aims are to: 
(a) statistically model the variables affecting uptake and coverage, (measures 
of the relationship between women invited, screened and the total eligible 
population); 
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(b) identify the variables affecting screening variation, attendance and round 
length, (measures of the elapsed time between when women are invited 
and when they are screened, involving current and previous episodes of 
screening); 
( c) determine the validity of the formulae used to calculate uptake and 
coverage, and make recommendations for future improvements of these 
formulae to the Breast Cancer Screening Programme; 
( d) develop intelligent computing techniques for predicting attendance and 
screening variation patterns at patient level, which will naturally lead to 
the prediction of uptake and coverage at aggregate level. 
1.4 Structure of the thesis 
The thesis is structured as follows. 
Chapter 1 presents a statement of the problem and outlines the aims of the study. A 
review of related current literature is carried out in Chapter 2, meanwhile the data 
acquisition and preparation is explained in Chapter 3. 
Chapter 4 concentrates on the statistical descriptive analysis. In particular, a sub-section 
is dedicated to the analysis of uptake and coverage focusing on the formulation of the 
revised formula proposed for measuring coverage, and presents other recommendations 
for the Breast Screening Programme. The significance of the results obtained by the 
statistical analysis is also discussed. 
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Chapter 5 introduces the artificial intelligence approach to predictive analysis. It focuses 
firstly on the analysis of the relationships and predictors of attendance and screening 
variation, and secondly on a description of the data and methods used to carry out the 
predictive analysis. 
Chapter 6 concentrates on the prediction of attendance using AI methodology compared 
with a well established statistical method as a benchmark. Formulation of a new 
algorithm for the prediction of attendance is presented as the closing section of this 
chapter. 
In Chapter 7, a similar approach to the one described in the previous chapter is used, but 
this time in relation to the prediction of screening variation. A consequent extension to 
the algorithm introduced is developed. 
Chapter 8 concentrates on a blind study focused on the prediction of attendance to the 
screening invitation using the proposed predictive algorithm. The discussion of the 
results obtained in the project and the conclusions drawn from these are presented in 
Chapter 9. 
Appendices A and B give the data tables and a graphical description of the impact of the 
screening variation per episode. Appendices C and E present the data tables of the 
predictive methods for attendance and screening variation respectively. Appendix D, on 
the other hand, shows the Decision trees obtained for the prediction of attendance and 
the decision rules for non-attendance. In Appendix F the predictive algorithm results for 
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the attendance of women to the screening invitation for the blind study are given. An 
exhaustive explanation of the classical statistical and predictive methods used can be 
found correspondly in Appendices G and H. Appendix I contains photocopies of the 
published papers. 
1.5 Dissemination of results 
Throughout the lifetime of this research, a number of publications have been 
disseminated to the specialist research community. 
Seven reviewed conference papers have been published, two of them in 2000 [54, 55], 
two in 2001 [56, 57], two in 2002 [58, 59] and one in 2003 [60]. In addition, two 
papers have been published in internal proceedings in Coventry University [61, 62]. A 
full report [63] has been submitted and approved by the sponsoring collaborating 




Following the statement of the problem outlined in Chapter 1, and the aims of our 
project, this chapter presents a review of the literature relevant to the development of the 
thesis. 
In this review, two main approaches need to be taken. The first is a review related to 
screening programmes, their development, analysis of performance and factors affecting 
them. The second approach deals with methodologies used to analyse medical data, 
specifically medical data mining and predictive methods applied in medicine, including 
the traditional statistical methods and the emerging use of artificial intelligence 
methodologies. 
2.1 Breast cancer screening programmes 
2.1.1 General overview 
As analysed by Forrest and colleagues in the report which laid the foundations for the 
implementation of the UK NHS Breast Screening Programme [4], up to 1986, numerous 
studies evaluating the effect of screening on breast cancer mortality were carried out 
worldwide. The successes reported by such studies encouraged the introduction of 
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organised population based breast-screening programmes in several countries, including 
the UK. 
As part of the steps towards the implementation of such programmes, three main 
subjects were discussed [8]: 
• the methods of screening: 
• Clinical Breast Examination (CBE) (19, 22] 
• Breast self-examination (BSE) (19, 22, 64] 
• Mammography[5,6, 11, 12,20,22,25,26,27,64-74] 
Screening with mammography being the most preferred methodology implemented. 
• the guidelines for the lower age limit of mammography screening [ 19]: 
• Younger than 40 years old (75] 
• 40 --49 years old (23, 64, 68, 75] 
• 50 years old (64, 68] 
50 years old being the most widely implemented. 
• the systems to recruit women to screening: 
• Invitation letter (6, 76] 
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• Invitation by phone 
• Others 
Invitation letters are the most widely reported implementation for first invitation to 
screening. 
All of the above subjects may be grouped under a main title, quality assurance activities, 
which are an evaluation priority for all the screening programmes [73], and for the IBSN 
(International Breast Cancer Screening Network) at world level. 
Particularly for the UK, several publications have been disseminated relating data tables, 
definitions and guidelines to methods of evaluation of the quality of the breast screening 
programme [77-79]. In addition, annual reviews of the UK NHS Breast Screening 
programme have been carried out since 1993 [13-17], [80]. 
Evaluation of the screening programme performance has been mainly focused on 
measures such as: 
• Death rates [5, 11, 12, 20, 21, 23, 26, 64-68, 81] 
• Uptake [6, 71, 73, 82-87] 
• Coverage [ 13-17] 
Although the coverage formulation has been well defined and accepted worldwide, the 
method_s by which the data is collected for its calculation vary from one country to 
another. In the UK, even though the data collection methodology has varied over the 
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years, no unified analysis taking the same approach of data collection has been reported. 
Moreover, no assessment of the coverage formulation has been reported to date, either. 
Uptake, as another proxy measurement of the programme performance, has been 
measured since the introduction of the programme in the UK (1989), monitored and 
reported annually by each screening unit and by the Breast Screening Programme 
nationally. It is a measure of how well the programme is accepted by those women 
invited. Nevertheless, no measure assessing how effective the programme is at inviting 
women has been defined. This may be due to a general belief that this issue is covered 
by the coverage formulation, but the latter parameter only measures the proportion of the 
population covered by screening, and assumes that those not screened are not attendees. 
A question arises then: could there be a percentage of this population that is not reached 
by the invitation process in the first instance? 
2.1.2 Factors influencing acceptance and 
participation 
Having accepted that screening programmes are a valuable means in the fight against 
breast cancer, the need for a closer look at the mechanisms of their operation becomes an 
important issue. The most important factor in determining the potential success of breast 
cancer screening programmes is the positive response of women to it. 
Increasing the response of women to breast screerung and the possible factors 
influencing their attendance have been a subject of great interest to researchers 
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worldwide. Studies related to this issue have been carried out in most countries where 
some form of screening programme has been implemented. 
In a broad sense, uptake is nothing more than an aggregate of the women's attendance to 
screening. Thus, in order to influence positive changes in the uptake, the acceptance and 
participation of women to screening invitations ought to be analysed. 
Attendance of women to screening programmes has been extensively studied worldwide 
through full population programmes and / or control based studies. Amongst the main 
factors reported as influencing the attendance of women to screening, the following can 
be mentioned: 
• age group [76, 82, 88] 
• previous health behaviour [22, 72, 85, 89, 72] 
• previous screening participation [22, 25, 72, 86, 89] 
• past uncomfortable experience of breast screening [90] 
• minority groups [69, 83, 89, 91] 
• socio-economic factors [70, 72, 82, 84, 85, 87-72, 92, 93] 
• previous cancer history [72] 
• distance to the screening facilities [76, 85, 88, 92] 
• density of medical amenities [88] 
• intrinsic factors associated with the programme [20, 25, 26, 85] 
• type of invitation [6, 87] 
• suffering from other medical problems [72, 82] 
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2.1.3 Attendance and social deprivation 
Socio-economic factors, and in particular poverty, are reported as having a significant 
influence on the attendance of women to screening [88]. 
Studies carried out in the UK which investigate parameters affecting uptake and their 
relationship with socio-economic factors concluded that variation in the uptake of breast 
cancer screening is closely related to social deprivation [84]. 
Several indices have been developed which aim at explaining the levels of poverty in 
different contexts. In the UK, the most common indices reported are, 
• Jannan Index 
• Carstairs Index 
• Townsend Deprivation Score 
• L WT Breadline Britain Index (L WT) 
• Index of Local Conditions (ILC) 
Based on the apparent influence that deprivation has on health-related outcomes, most of 
the social-deprivation analyses are based on the Townsend deprivation score [94]. The 
selection of this particular score has its foundations in the results obtained through a UK.-
based research by Payne, Payne and Hyde [95]. Although primarily directed at 
sociologists, this study analyses the different indices of poverty and social deprivation, 
highlighting the importance of social deprivation indices in society, in general, and how 
it operates for different groups. One important conclusion reported in this work with 
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relevance to ours, is that the Townsend deprivation score, out of all the other mentioned 
social-deprivation indices, is the one that relates more closely to all the other indices. In 
other words, the Townsend deprivation score groups in itself the factors taken into 
account by the other indices. This conclusion gives, as such, strong justification for the 
use of this particular score when analysing the effect of social deprivation on attendance 
to breast cancer screening. 
Nevertheless, the use of this score needs to be carefully monitored, because, as reported 
by Collins et al. [96], Townsend score can report higher values than reality when 
individual addresses are used to match enumeration districts via the address postcode. It 
is suggested that for problems involving resource allocation and for research into 
relationships between health outcomes or service uptake and deprivation, it may be 
necessary to quantify the level of error introduced through using postcode to 
enumeration district matching. Focusing particularly on breast cancer screening in the 
UK, a more appropriate matching of individuals' addresses to deprivation scores should 
be developed by the units when taking this factor as a predictor for attendance [87). 
A possible solution to this problem, not discussed in the literature, could be to use 
intervals of values of the Townsend deprivation score (discretisation of the variable), 
instead of using the original continuous values. 
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2.1.4 Delayed attendance and slippage 
Although the subject of screening appointment changes by women is raised in the 
literature, no analysis of the influence of these factors has been reported for non-
symptomatic women. Neither has a study of the effect that these appointment changes 
can have on the programme performance been reported. As a direct consequence, no 
attempt to predict women's change of appointments has been reported. 
Nevertheless, studies carried out focusing on symptomatic women have analysed factors 
predicting delayed presentation to screening [97]. Amongst such factors, those that could 
be equally relevant to non-symptomatic women are: 
• Age group 
• Marital status 
• Education level 
• Ethnicity, minority groups 
Delayed attendance, on the other hand, is closely related to screening round slippage 
(rounds longer than 3 years) and interval cancers (cancers detected between two 3-year 
interval screenings). These two factors are publicly recognised to affect breast cancer 
screening programmes [7, 90, 98]. 
Round slippage by itself, on the other hand, can have an impact on the increment of 
interval cancers. Although Threlfall et al. [99] proposed, as a way of decreasing interval 
cancersy to offer younger women in the programme screenings at less than the actual 
three years interval. 
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A more radical suggestion was proposed by Faux et al. [24]. They proposed that the 
definition of interval cancers should be changed to include cancers arising at 36 months 
(3 years) or more from the last screening. Their conclusion was that the exclusion criteria 
used in the present definition of interval cancers had a significant impact on observed 
interval cancer rates. 
Threlfall et al. stated: 
"The occurrence of some interval cancer is inevitable, but a high rate of interval 
cancers may indicate poor sensitivity or an unsuitable long screening round, or both". 
[99] 
They also highlight problems arising due to the programme structure of invitations. In 
reality, all women are not screened at exactly three yearly intervals as it is assumed, but 
rather in longer or shorter time periods. They concluded that the exclusion of those 
cancers from interval cancer data masked the problem of late re-invitation. They fail to 
point to another problem masked under the same umbrella, the problem raised by the 
women's changes in dates of screening appointments (delayed attendance). 
2.1.5 Interventions to prevent delayed attendance 
and non-attendance 
There is a recognised believe that there exist significant differences between previous 
participants and non-participants [ 6, 25], and that determination of intentions and past 
screening behaviour could be used to improve participation and adherence to breast 
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cancer screening programmes. Once those women likely not to attend or incur a delayed 
presentation are identified, appropriate interventions could be taken to avoid or minimise 
this behaviour. 
Several typical actions have been identified and reported. Amongst those are: 
• re-invitations [6, 71, 72, 87] 
• general practitioner (GP) letter addressing [71, 83] 
• reminder letters [70, 71] 
• phone calls [70] 
• physician recommendation [22, 70, 71, 72, 83, 86, 100] 
• cultural relativistic approach [69, 83, 86, 91] 
• clinic based interventions [70, 90] 
• patient education [70, 71, 86] 
• increase staff [70] 
• offer of transport to the screening centre [83] 
2.2 Prediction of attendance 
Identification of predictive factors of attendance to screening has been discussed and 
reported extensively in the literature. Amongst the predictors of attendance to screening 
has been cited, 
• physician recommendation [22, 72, 87, 100] 
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• age group [22, 82, 88] 
• household income [22, 70, 82] 
• deprivation [82, 87, 88] 
• previous screening behaviour [6, 25, 72, 86] 
• intention of participation [25, 86] 
• consequences of screening [25, 100] 
• marital status [72, 82, 86] 
• employment status [71] 
• previous experience of cancer [72] 
However, although such identification has been achieved, no attempt to predict 
attendance from patient level information has been carried out. 
2.2.1 Methodology overview and predictive 
analysis approach 
The methodology used for prediction in the medical literature can be subdivided in, 
• social cognition models [86, 100, 101] 
• statistical methods [25, 72, 73-75, 86, 87, 100, 102-108] 
• fuzzy logic methods [51, 52, 109] 
• rule induction and genetic algorithms [109-111] 
• artificial neural networks [49, 50, 51, 52, 102-105, 107-110, 112, 113, 
124-127] 
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The most reported social cognition models are: 
• The Health Believe Model [86, 100] 
• The Theory of Planned behaviour [86, 101] 
However, the data available for this study do not allow a successful implementation of 
these approaches as it does not include sufficient socio-economic information relating to 
individual women. 
Consequently, this review will concentrate on statistical and artificial intelligence 
methods. 
2.2.1.1 Statistical methods 
Statistical methods are well recognised by the scientific community, and especially well 
established amongst the medical community. In particular, they are recognised as 
successful tools in medical applications for the prediction (and / or prognosis) of 
different medical features. The most reported statistical methods used for these purposes 
are: 
• Logistic regression [25, 51, 52, 87, 72, 102, 105, 124] 
• Markov chains [74, 75] 
• Cox regression [102-104, 106-108] 
• Principal components analysis [105] 
• Factorial analysis 
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• Discrimination analysis [109] 
• Bayesian likelihood analysis [73] 
Most of the studies in the previous sections, used statistical methods in their design and 
analysis. 
Statistical methods, successfully applied in medical research, are documented in various 
reference books, which give exhaustive explanations of them. Particularly relevant 
discussions of the most commonly used techniques can be found in Armitage [28], Puri 
[29], Altman [30], Bland [31], Collet [41], Agresti [42, 43], Cox [44], Hosmer & 
Lemeshow [46], McCullagh & Nelder [47], Cooper [114], and Everitt [115]. These 
books are also mentioned as references for computational implementations of the 
methods in well-established statistical software packages such as SPSS, Clementine and 
Unistat. 
2.2.1.2 Artificial intelligence methods 
More recently, artificial intelligence methods (Al) have emerged as potentially powerful 
tools in medical applications. 
However, the introduction of new techniques in a well-established area is always 
controversial. In defence of the introduction of the use of Artificial Neural Networks 
(ANN) in Biomedicine, Burke [112] expressed a main paradigm: 
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"It is difficult for traditional statistical methods to capture complex systems because 
traditional methods attempt to find the model that best fits the statistician 's 
understanding of the phenomenon; complex systems are difficult to understand and 
therefore difficult to fit with a simple model. Artificial neural networks are 
nonparametric regression models. They capture any phenomena, to any degree of 
accuracy (depending on the adequacy of the data and the power of the predictors), 
without prior knowledge of the phenomena. . .. Artificial neural networks are a powerful 
method for capturing complex phenomena, but their use requires a paradigm shift, from 
exploratory analysis of the data to exploratory analysis of the model" 
Several reference books are reported as classics for AI methods and algorithms, e.g. 
Goldberg [39]. More specifically, Patterson [32], Ripley [33], Berry & Linoff [34], 
Bigus [35], Bishop [36], and Masters [37, 38] deal with ANN, while Berry [34], Mitchell 
[ 40] and Quinlan [ 41] deal with Rule induction and Decision trees methods. Many of 
these references are also cited in the documentation of algorithms implemented as part of 
Clementine and several libraries of Matlab. 
Rule induction techniques and genetic algorithms applications have been used and 
recommended when generating classification rules and are particularly useful in carrying 
out exploratory analysis of generated models. However, the dimensionality occurring 
when dealing with large databases involving a large number of features is a common 
problem encountered [109]. 
In particular, applications of ANN have been reported, as often achieving better results 
than the statistical methods in 
' 
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• Survival analysis [102-105, 107, 113, 124, 125] 
• Medical prognosis [102, 104, 105, 107, 112, 125, 126] 
• Treatment outcome [103, 108] 
• Disease classification [49, 109, 110, 127] 
amongst others. 
Nevertheless, when applying ANNs in medical data some common pitfalls should be 
avoided. Schwarzer et al. [116], provide a good discussion of current approaches and 
their comparison with statistical methods (particularly Logistic regression). Frequent 
criticisms of applying ANN methods are: 
• Doubtful convergence to the real function that they are approximating 
in cases of small data 
• Careful selection of the sample size needed in order to have an 
accurate estimation of misclassification probabilities 
• Risk of over-training 
• Non separation of the data into training, validation and test data sets 
• Reporting results comparisons with inappropriate statistical methods 
Although such points are normally raised by retractors of the use of AI methodology in 
oncology, the points raised are valid and need consideration when applying and 
reporting results obtained by means of the use of these approaches. 
24 
Concentrating on applications of ANNs in the medical environment; it can be said that, 
although an extensive variety of methods have been exploited, some of the most 
common ANN methods applied in the medical context are: 
• Feed forward back propagation neural networks [51, 52, 102, 
107, 108, 110, 112, 124, 125, 127] 
• Radial basis functions [49] 
• Pruning neural networks [ 113] 
No reports could be found that discuss any of these methods in relation to the prediction 
of attendance to screening. 
2.2.2 Prediction of attendance to full population 
based breast cancer screening programme 
As demonstrated by the literature discussed in previous sections, prediction of 
attendance could clearly facilitate an improvement in the outcomes of the UK NHS 
Breast screening programme. 
An attempt to predict attendance was carried out by Lancucki & Babb [53]. Using 
reported data from the UK NHS breast screening programme, they proposed the use of a 
new measure of uptake based on the estimated cumulative attendance (ECA), i.e. the 
prediction of the attendance as a cumulative frequency. They claim that this measure has 
the adv~tage of being a summary statistic that can be evaluated from year to year. This 
is the estimated percentage of total possible women-attendances which would occur if 
25 





























































































































































